Company intelligence / Profile preview

Collegium Pharmaceutical

Stoughton, Massachusetts, United Statescollegiumpharma.com ↗

Ownership: Public · COLL
Employees: ~357
Development stage: Commercial

Overview

Collegium has successfully commercialized several differentiated medications for serious medical conditions—primarily chronic and acute pain—using proprietary abuse-deterrent technologies. Its lead products are Xtampza ER, Nucynta franchise, Belbuca, Symproic, and Elyxyb. The company has expanded through acquisitions of BioDelivery Sciences International and Ironshore Therapeutics in recent years. Clinical results have led to multiple FDA approvals.

Therapeutic areas: GastroenterologyPsychiatryNeurology
Modalities: Small moleculesExtended-release formulations
Industry: Biotech

Drug pipeline

7 assets

Painkyl

Approved

6 more assets in the full pipeline.

Request access →

Partnerships

Hikma Pharmaceuticals – authorized generic agreement for Nucynta franchise products.

Financials

Market cap: $743.4M
Total revenue: $199.9M
Enterprise value: $1.5B

Beyond the preview

Go deeper on Collegium Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collegium Pharmaceutical.

Explore the full profile